Abstract:Background: IBS and IBD are chronic gastrointestinal (GI) conditions associated with abdominal pain and abnormal bowel habits.Although IBS and IBD share common symptoms, their pathogenesis differs.Whereas IBD symptoms often arise from inflammatory or structural abnormalities, these objective markers are not consistently identified in IBS.Because symptom pathogenesis differs between disorders, we aimed to test whether symptom severity also varies between IBS and IBD.Methods: We compared GI symptoms using items developed for the NIH Patient Reported Outcome Measurement Information System (PROMIS®) that assessed frequency, severity, interference, and bother to 3 groups: (1) IBS patients from clinic and community populations, (2) IBD clinic patients, and (3) a U.S. general population (GP) sample selected by a commercial research firm (Cint) to approximate characteristics in the 2010 census.We measured 8 GI symptom domains: gastroesophageal reflux (GERD), disrupted swallowing, nausea/vomiting (N/V), belly pain, diarrhea, constipation, gas/bloating, and fecal incontinence/soling (FI).We measured overall symptom severity by averaging responses to items and transforming linearly to a 0-100 possible range (higher=worse).We compared group differences using analysis of covariance controlling for demographics and GI symptom-specific anxiety (Visceral Sensitivity Index [VSI]).To adjust for multiple comparisons for different symptoms, a p ,0.01 was used.Results: Respondents included 231 with IBS (mean age=44.8yrs; 68%F; 56.3% Caucasian), 190 with IBD (mean age=41.3yrs; 46%F; 58.4% Caucasian) and 1117 from the GP (mean age 45.7; 57%F; 72.7% Caucasian).Mean age, race/ethnicity, and education significantly differed between groups (all p ,0.01).The Table shows differences in GI symptom severity scores between groups.The GP had greater severity of GERD, disrupted swallowing and N/V compared to the patient groups.GERD severity differed among all groups with greatest severity in GP, followed by IBS, and then IBD.GP reported more disrupted swallowing than IBS and greater N/V than IBD.IBS patients reported greater severity of belly pain vs. GP and greater severity of constipation and gas/ bloating vs. GP and IBD.IBD patients had more severe diarrhea than the GP but not IBS.Conclusions: While IBS and IBD are conditions associated with greater lower GI symptom severity compared to the GP, they report less severe upper GI symptoms.Between disease states, IBS patients report numerically worse symptom severity vs. IBD for 7 of 8 GI symptom domains -only diarrhea appeared more severe in IBD.Although IBD is marked by objective inflammatory and anatomic biomarkers, this does not necessarily yield worse symptom severity than IBS -a condition without reliable biomarkers; the converse is true in this study.* P values after controlling for demographics and VSI.Values shown in bold are statistically significant.

A clinical study on functional dyspepsia based on Rome III criteria

A Clinical Study on Functional Dyspepsia Based on Rome Ⅲ Criteria

Prevalence and Risk Factors for Functional Bowel Disorders in South China: a Population Based Study Using the Rome III Criteria.

Characteristics and risk factors of Functional Dyspepsia fulfilling the Rome IV Criteria overlapping with Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China

Gastrointestinal Symptoms and Associated Factors in Chinese Patients with Functional Dyspepsia

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

Houpu Paiqi mixture in treatment of functional dyspepsia:a multicenter randomized controlled study

The clinical characteristics of functional dyspepsia in Fujian province

The Value of Rome Ⅲ Criteria in Diagnosis and Differentiation of Functional Dyspepsia

Epidemiological and clinical features of functional dyspepsia in a region with a high incidence of esophageal cancer in China

The Spectra, Symptom Profiles and Overlap of Rome III Functional Gastrointestinal Disorders in a Tertiary Center in South China

Rome Iii, Rome Iv, And Potential Asia Symptom Criteria For Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease

Gastric motor and sensory function in patients with functional dyspepsia diagnosed based on the Rome Ⅲ Criteria

The Epidemiological Study of GERD and FGID

Positive Endoscopic and Ultrasonographic Findings in Patients with Symptom‐diagnosed Functional Gastrointestinal Disorder: Data from a Chinese Cross‐sectional Study

Certain Dietary Habits Contribute to the Functional Dyspepsia in South China Rural Area.

[A Clinical Study of Functional Dyspepsia and Mental Disorder Co-Morbidity].

Do Different Types Of Patients With Functional Dyspepsia In Rome Iii Criteria Vary In Related Pathophysiological Mechanisms?

Solid gastric emptying function in patients with functional dyspepsia fulfilling Rome III criteria

Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.